You searched for
Category:
#CareBeyondTreatment
Chiesi Partnership Day 2023
17/11/2023
Chiesi Open Day 2023: a day of sharing and discovery
24/10/2023
A behavioral therapy app to close the access gap in COPD treatment
18/04/2023
Rare Disease Day
28/02/2023
Fostering innovation for rare diseases in Europe: Chiesi supports the RDR Challenges Call
27/10/2022
The Art of Healing
08/06/2022
A musical manifesto to rewrite the future
23/05/2022
World Prematurity Day: Chiesi’s commitment for the premature babies
30/11/2021
World Prematurity Day: Chiesi is at the forefront for preterm babies
16/11/2020
Chiesi USA, Inc. announces FDA approval of Bronchitol® (mannitol) inhalation powder
02/11/2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
28/05/2020
Chiesi Group and Apotex Inc. finalize agreement for acquisition of Ferriprox® (deferiprone)
13/01/2020
Chiesi Group Announces Closing of Licensing Transaction with Santhera for an orphan drug in LHON
02/08/2019
Chiesi Group signs an Option Agreement with Inhibrx for Development and Commercialization of INBRX-101 (AAT-Fc)
30/05/2019
Chiesi Group Enters into License Agreement with Santhera for a treatment for LHON
23/05/2019